A citation-based method for searching scientific literature

Alon Grossman, Ehud Grossman. Cardiovasc Diabetol 2017
Times Cited: 29







List of co-cited articles
93 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Effects of intensive blood-pressure control in type 2 diabetes mellitus.
William C Cushman, Gregory W Evans, Robert P Byington, David C Goff, Richard H Grimm, Jeffrey A Cutler, Denise G Simons-Morton, Jan N Basile, Marshall A Corson, Jeffrey L Probstfield,[...]. N Engl J Med 2010
24

2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8).
Paul A James, Suzanne Oparil, Barry L Carter, William C Cushman, Cheryl Dennison-Himmelfarb, Joel Handler, Daniel T Lackland, Michael L LeFevre, Thomas D MacKenzie, Olugbenga Ogedegbe,[...]. JAMA 2014
24

A Randomized Trial of Intensive versus Standard Blood-Pressure Control.
Jackson T Wright, Jeff D Williamson, Paul K Whelton, Joni K Snyder, Kaycee M Sink, Michael V Rocco, David M Reboussin, Mahboob Rahman, Suzanne Oparil, Cora E Lewis,[...]. N Engl J Med 2015
20

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
20


Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease.
Rhonda M Cooper-DeHoff, Yan Gong, Eileen M Handberg, Anthony A Bavry, Scott J Denardo, George L Bakris, Carl J Pepine. JAMA 2010
434
13

Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis.
Connor A Emdin, Kazem Rahimi, Bruce Neal, Thomas Callender, Vlado Perkovic, Anushka Patel. JAMA 2015
388
13


Effects of intensive glucose lowering in type 2 diabetes.
Hertzel C Gerstein, Michael E Miller, Robert P Byington, David C Goff, J Thomas Bigger, John B Buse, William C Cushman, Saul Genuth, Faramarz Ismail-Beigi, Richard H Grimm,[...]. N Engl J Med 2008
10

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.
Aram V Chobanian, George L Bakris, Henry R Black, William C Cushman, Lee A Green, Joseph L Izzo, Daniel W Jones, Barry J Materson, Suzanne Oparil, Jackson T Wright,[...]. JAMA 2003
10

Cardiorenal end points in a trial of aliskiren for type 2 diabetes.
Hans-Henrik Parving, Barry M Brenner, John J V McMurray, Dick de Zeeuw, Steven M Haffner, Scott D Solomon, Nish Chaturvedi, Frederik Persson, Akshay S Desai, Maria Nicolaides,[...]. N Engl J Med 2012
753
10

Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.
Dena Ettehad, Connor A Emdin, Amit Kiran, Simon G Anderson, Thomas Callender, Jonathan Emberson, John Chalmers, Anthony Rodgers, Kazem Rahimi. Lancet 2016
10

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Steven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann, Michael A Nauck, Steven E Nissen, Stuart Pocock, Neil R Poulter, Lasse S Ravn,[...]. N Engl J Med 2016
10

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R Matthews. N Engl J Med 2017
10

Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension.
Alexander A Leung, Kara Nerenberg, Stella S Daskalopoulou, Kerry McBrien, Kelly B Zarnke, Kaberi Dasgupta, Lyne Cloutier, Mark Gelfer, Maxime Lamarre-Cliche, Alain Milot,[...]. Can J Cardiol 2016
304
10

2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Paul K Whelton, Robert M Carey, Wilbert S Aronow, Donald E Casey, Karen J Collins, Cheryl Dennison Himmelfarb, Sondra M DePalma, Samuel Gidding, Kenneth A Jamerson, Daniel W Jones,[...]. Hypertension 2018
10


Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries.
Katherine T Mills, Joshua D Bundy, Tanika N Kelly, Jennifer E Reed, Patricia M Kearney, Kristi Reynolds, Jing Chen, Jiang He. Circulation 2016
10

2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
Giuseppe Mancia, Guy De Backer, Anna Dominiczak, Renata Cifkova, Robert Fagard, Giuseppe Germano, Guido Grassi, Anthony M Heagerty, Sverre E Kjeldsen, Stephane Laurent,[...]. J Hypertens 2007
6

Effects of candesartan compared with amlodipine in hypertensive patients with high cardiovascular risks: candesartan antihypertensive survival evaluation in Japan trial.
Toshio Ogihara, Kazuwa Nakao, Tsuguya Fukui, Kohshiro Fukiyama, Kenji Ueshima, Koji Oba, Tosiya Sato, Takao Saruta. Hypertension 2008
173
6

Metabolic and cardiovascular effects of carvedilol and atenolol in non-insulin-dependent diabetes mellitus and hypertension. A randomized, controlled trial.
D Giugliano, R Acampora, R Marfella, N De Rosa, P Ziccardi, R Ragone, L De Angelis, F D'Onofrio. Ann Intern Med 1997
217
6

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.
E J Lewis, L G Hunsicker, W R Clarke, T Berl, M A Pohl, J B Lewis, E Ritz, R C Atkins, R Rohde, I Raz. N Engl J Med 2001
6

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.
B M Brenner, M E Cooper, D de Zeeuw, W F Keane, W E Mitch, H H Parving, G Remuzzi, S M Snapinn, Z Zhang, S Shahinfar. N Engl J Med 2001
6


2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension.
Giuseppe Mancia, Guy De Backer, Anna Dominiczak, Renata Cifkova, Robert Fagard, Giuseppe Germano, Guido Grassi, Anthony M Heagerty, Sverre E Kjeldsen, Stephane Laurent,[...]. J Hypertens 2007
6


Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study.
A I Adler, I M Stratton, H A Neil, J S Yudkin, D R Matthews, C A Cull, A D Wright, R C Turner, R R Holman. BMJ 2000
6

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial.
Stevo Julius, Sverre E Kjeldsen, Michael Weber, Hans R Brunner, Steffan Ekman, Lennart Hansson, Tsushung Hua, John Laragh, Gordon T McInnes, Lada Mitchell,[...]. Lancet 2004
6


Combined angiotensin inhibition for the treatment of diabetic nephropathy.
Linda F Fried, Nicholas Emanuele, Jane H Zhang, Mary Brophy, Todd A Conner, William Duckworth, David J Leehey, Peter A McCullough, Theresa O'Connor, Paul M Palevsky,[...]. N Engl J Med 2013
614
6

Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators.
J Tuomilehto, D Rastenyte, W H Birkenhäger, L Thijs, R Antikainen, C J Bulpitt, A E Fletcher, F Forette, A Goldhaber, P Palatini,[...]. N Engl J Med 1999
673
6



Cardiovascular events during differing hypertension therapies in patients with diabetes.
Michael A Weber, George L Bakris, Kenneth Jamerson, Matthew Weir, Sverre E Kjeldsen, Richard B Devereux, Eric J Velazquez, Björn Dahlöf, Roxzana Y Kelly, Tsushung A Hua,[...]. J Am Coll Cardiol 2010
128
6

Potential role of sodium glucose cotransporter 2 inhibitors in the treatment of hypertension.
Ilkka Tikkanen, Robert Chilton, Odd Erik Johansen. Curr Opin Nephrol Hypertens 2016
26
7

Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association.
Richard W Nesto, David Bell, Robert O Bonow, Vivian Fonseca, Scott M Grundy, Edward S Horton, Martin Le Winter, Daniel Porte, Clay F Semenkovich, Sidney Smith,[...]. Diabetes Care 2004
533
6

2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
Giuseppe Mancia, Robert Fagard, Krzysztof Narkiewicz, Josep Redón, Alberto Zanchetti, Michael Böhm, Thierry Christiaens, Renata Cifkova, Guy De Backer, Anna Dominiczak,[...]. J Hypertens 2013
6



Prevalence of hypertension and controlled hypertension - United States, 2007-2010.
Cathleen D Gillespie, Kimberly A Hurvitz. MMWR Suppl 2013
128
6


Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.
Christoph Wanner, Silvio E Inzucchi, John M Lachin, David Fitchett, Maximilian von Eynatten, Michaela Mattheus, Odd Erik Johansen, Hans J Woerle, Uli C Broedl, Bernard Zinman. N Engl J Med 2016
6

Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.
George L Bakris, Vivian Fonseca, Richard E Katholi, Janet B McGill, Franz H Messerli, Robert A Phillips, Philip Raskin, Jackson T Wright, Rosemary Oakes, Mary Ann Lukas,[...]. JAMA 2004
502
6

Effects of the glucagon-like peptide-1 receptor agonist liraglutide on 24-h ambulatory blood pressure in patients with type 2 diabetes and stable coronary artery disease: a randomized, double-blind, placebo-controlled, crossover study.
Preman Kumarathurai, Christian Anholm, Andreas Fabricius-Bjerre, Olav W Nielsen, Ole Kristiansen, Sten Madsbad, Steen B Haugaard, Ahmad Sajadieh. J Hypertens 2017
24
8

A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
Carl J Pepine, Eileen M Handberg, Rhonda M Cooper-DeHoff, Ronald G Marks, Peter Kowey, Franz H Messerli, Giuseppe Mancia, José L Cangiano, David Garcia-Barreto, Matyas Keltai,[...]. JAMA 2003
863
6

The role of the kidneys in glucose homeostasis: a new path towards normalizing glycaemia.
R A DeFronzo, J A Davidson, S Del Prato. Diabetes Obes Metab 2012
316
6


Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies.
N Sarwar, P Gao, S R Kondapally Seshasai, R Gobin, S Kaptoge, E Di Angelantonio, E Ingelsson, D A Lawlor, E Selvin, M Stampfer,[...]. Lancet 2010
6

Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus.
P Michael Ho, John S Rumsfeld, Frederick A Masoudi, David L McClure, Mary E Plomondon, John F Steiner, David J Magid. Arch Intern Med 2006
737
6

Translating the A1C assay into estimated average glucose values.
David M Nathan, Judith Kuenen, Rikke Borg, Hui Zheng, David Schoenfeld, Robert J Heine. Diabetes Care 2008
887
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.